title: Allogeneic bone marrow transplantation in multiple myeloma: a report of four cases.
abstract: Allogeneic bone marrow transplantation offers a new and promising form for treatment of multiple myeloma incurable with chemotherapy. We present four cases of advanced multiple myeloma given bone marrow transplantation from HLA-identical and MLC-negative sibling donors. One patient had a recurrent plasmacytoma 8 months later and one died 12 days after the transplantation whereas the other two are in good clinical remission 15 and 19 months post-transplantation.
authors.affiliation: Department of Medicine, Turku University Central Hospital, Finland.
authors.forename: J
authors.initials: J
authors.lastname: Nikoskelainen
authors.forename: K
authors.initials: K
authors.lastname: Koskela
authors.forename: K
authors.initials: K
authors.lastname: Kätkä
authors.forename: T T
authors.initials: TT
authors.lastname: Pelliniemi
authors.forename: J
authors.initials: J
authors.lastname: Kulmala
authors.forename: T
authors.initials: T
authors.lastname: Salmi
authors.forename: A
authors.initials: A
authors.lastname: Toivanen
mesh_terms: D000328:Adult; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology; D006680:HLA Antigens; D006801:Humans; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000276:immunology / Q000628:therapy*
chemical_list: D006680:HLA Antigens; D003520:Cyclophosphamide